Future investigations of CLOCK:BMAL1 metabolic regulation in the context of suicide attempts may help move towards biologically-augmented pharmacotherapy selection and stratification of suicide risk and for patients with MDD based upon their lifetime history of attempted suicide. The gene discussed is BMAL1; the disease is major depressive disorder.